CF ON3 Lifesciences Parent DST — Form D/A
CF ON3 Lifesciences Parent DST of NEW YORK, NY, a company, filed a Form D amendment with the SEC on 2023-02-28. The offering totals $69.8M, of which $69.8M was reported sold. Industry: Other Real Estate.
Offering
- Filed: 2023-02-28
- Form: D/A
- Accession: 0001928276-23-000001
- Industry: Other Real Estate
- Exemptions: 06b
- Total offering: $69.8M
- Amount sold: $69.8M
- Minimum investment: $250K
- Investors: 116
- Date of first sale: 2022-05-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-446573
Issuer
- Name: CF ON3 Lifesciences Parent DST
- CIK: 0001928276
- Entity type: Other
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: C/O CANTOR FITZGERALD INVESTORS, LLC, NEW YORK, NY, 10022
- Phone: 2129385000
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| N/A Cantor Fitzgerald Investors, LLC | Executive Officer | New York, NY |
| N/A CF ON3 Lifesciences Depositor, LLC | Executive Officer | New York, NY |
| N/A CF ON3 Lifesciences DST Manager, LLC | Executive Officer | New York, NY |
| N/A CF ON3 Lifesciences Parent Manager, LLC | Executive Officer | New York, NY |
Other filings by this issuer (1)
More